Ann De Vos

1.6k total citations
20 papers, 710 citations indexed

About

Ann De Vos is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Ann De Vos has authored 20 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Psychiatry and Mental health. Recurrent topics in Ann De Vos's work include Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (6 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Ann De Vos is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (6 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Ann De Vos collaborates with scholars based in Belgium, Sweden and United Kingdom. Ann De Vos's co-authors include Eugeen Vanmechelen, Kaj Blennow, Henrik Zetterberg, Joris Winderickx, Dirk Jacobs, Sebastiaan Engelborghs, Fred Van Leuven, Thomas Vanhelmont, Harald Hampel and Hanne Struyfs and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Chemistry and Analytica Chimica Acta.

In The Last Decade

Ann De Vos

20 papers receiving 702 citations

Peers

Ann De Vos

PHYSI

PMH

NEURO

Jong‐Chan Park South Korea

Jurre den Haan Netherlands

Martha Foiani United Kingdom

Chloe K. Nobuhara United States

Matthew Zimmermann Australia

Natalia Lelental Germany

Joakim Hertze Sweden

Timo Jan Oberstein Germany

C M Hulette United States

Lani Clinton United States

Jong‐Chan Park South Korea

Ann De Vos

443 ×1.0

PHYSI

299 ×1.1

182 ×0.7

PMH

242 ×1.9

NEURO

52 ×0.5

NEURO

Citations per year, relative to Ann De Vos Ann De Vos (= 1×) peers Jong‐Chan Park

Countries citing papers authored by Ann De Vos

Since Specialization

Citations

This map shows the geographic impact of Ann De Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann De Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann De Vos more than expected).

Fields of papers citing papers by Ann De Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann De Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann De Vos. The network helps show where Ann De Vos may publish in the future.

Co-authorship network of co-authors of Ann De Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Ann De Vos. A scholar is included among the top collaborators of Ann De Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann De Vos. Ann De Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vergallo, Andrea, Pablo Lemercier, Enrica Cavedo, et al.. (2021). Plasma β‐secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD. Alzheimer s & Dementia. 17(4). 629–640. 17 indexed citations

Zhang, Min, Xiaomei Zhong, Eugeen Vanmechelen, et al.. (2020). BACE1 and Other Alzheimer’s-Related Biomarkers in Cerebrospinal Fluid and Plasma Distinguish Alzheimer’s Disease Patients from Cognitively-Impaired Neurosyphilis Patients. Journal of Alzheimer s Disease. 77(1). 313–322. 9 indexed citations

Chiesa, Patrizia A., Marion Houot, Andrea Vergallo, et al.. (2019). Association of brain network dynamics with plasma biomarkers in subjective memory complainers. Neurobiology of Aging. 88. 83–90. 5 indexed citations

Vergallo, Andrea, Marion Houot, Enrica Cavedo, et al.. (2019). Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD. Alzheimer s & Dementia. 15(10). 1274–1285. 23 indexed citations

Vergallo, Andrea, Simone Lista, Enrica Cavedo, et al.. (2019). Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease. Alzheimer s & Dementia. 15(6). 764–775. 123 indexed citations

Schipke, Carola G., Ann De Vos, Manuel Fuentes, et al.. (2018). Neurogranin and BACE1 in CSF as Potential Biomarkers Differentiating Depression with Cognitive Deficits from Early Alzheimer’s Disease: A Pilot Study. Dementia and Geriatric Cognitive Disorders Extra. 8(2). 277–289. 19 indexed citations

Ruı́z, E., Deborah Decrop, Karen Leirs, et al.. (2018). Digital ELISA for the quantification of attomolar concentrations of Alzheimer's disease biomarker protein Tau in biological samples. Analytica Chimica Acta. 1015. 74–81. 73 indexed citations

Willemse, Eline A.J., Ann De Vos, Elizabeth Herries, et al.. (2018). Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study. Clinical Chemistry. 64(6). 927–937. 32 indexed citations

Vos, Ann De, Maria Bjerke, Raf Brouns, et al.. (2017). Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke. BMC Neurology. 17(1). 170–170. 68 indexed citations

10.

Willemse, Eline A.J., Ann De Vos, Elizabeth Herries, et al.. (2017). [O1–05–04]: CLINICAL PERFORMANCE OF NEUROGRANIN AS A CEREBROSPINAL FLUID BIOMARKER FOR ALZHEIMER's DISEASE: AN ASSAY COMPARISON STUDY. Alzheimer s & Dementia. 13(7S_Part_4). 4 indexed citations

11.

Vos, Ann De, Hanne Struyfs, Dirk Jacobs, et al.. (2016). The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer’s Disease. Journal of Alzheimer s Disease. 53(4). 1523–1538. 46 indexed citations

12.

Vos, Ann De, Julia Ring, Frank Madeo, et al.. (2015). The peptidyl prolyl cis/trans isomerase Pin1/Ess1 inhibits phosphorylation and toxicity of tau in a yeast model for Alzheimer’s disease. SHILAP Revista de lepidopterología. 2(2). 144–160. 8 indexed citations

13.

Vos, Ann De, Dirk Jacobs, Hanne Struyfs, et al.. (2015). C‐terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease. Alzheimer s & Dementia. 11(12). 1461–1469. 125 indexed citations

14.

Vos, Ann De, Dirk Jacobs, Hanne Struyfs, et al.. (2015). P4‐232: A monoclonal antibody‐based elisa for neurogranin. Alzheimer s & Dementia. 11(7S_Part_19). 1 indexed citations

15.

Vanmechelen, Eugeen, Ann De Vos, Erik Portelius, Kaj Blennow, & Henrik Zetterberg. (2014). Tau as a molecular biomarker in cerebrospinal fluid and plasma. Neurobiology of Aging. 35. S23–S23. 1 indexed citations

16.

Vos, Ann De, Dirk Jacobs, Eugeen Vanmechelen, et al.. (2013). O2–09–03: Detection and quantification of novel tau/phospho‐tau epitopes in CSF using a multiplex assay approach. Alzheimer s & Dementia. 9(4S_Part_8). 2 indexed citations

17.

Vos, Ann De, et al.. (2011). Yeast as a Model System to Study Tau Biology. International Journal of Alzheimer s Disease. 2011(1). 428970–428970. 28 indexed citations

18.

Vanhelmont, Thomas, Ann De Vos, Dick Terwel, et al.. (2010). Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast. FEMS Yeast Research. 10(8). 992–1005. 38 indexed citations

19.

Winderickx, Joris, Charlotte Delay, Ann De Vos, et al.. (2008). Protein folding diseases and neurodegeneration: Lessons learned from yeast. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783(7). 1381–1395. 84 indexed citations

20.

Vos, Ann De, Liesbeth Vervoort, & Renaat Kinget. (1994). Release of Indomethacin from Transparent Oil–Waters Gels. Journal of Pharmaceutical Sciences. 83(5). 641–643. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact